Clearside Biomedical (NASDAQ:CLSD) reported its Q3 earnings results on Monday, November 13, 2023 at 04:05 PM.
Here’s what investors need to know about the announcement.
Earnings
Clearside Biomedical reported in-line EPS of $-0.15 versus an estimate of $-0.15.
Revenue was up $593 thousand from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.01 which was followed by a 6.6% drop in the share price the next day.
Here’s a look at Clearside Biomedical’s past performance:
| Quarter | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.14 | -0.14 | -0.13 | -0.03 |
| EPS Actual | -0.15 | -0.15 | -0.16 | -0.13 |
| Revenue Estimate | 120K | 140K | 100K | 6.52M |
| Revenue Actual | 1.02M | 4K | 330K | 266K |
To track all earnings releases for Clearside Biomedical visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
